Skip to main content
Have a personal or library account? Click to login
Electrogene therapy with interleukin-12 in canine mast cell tumors Cover

Electrogene therapy with interleukin-12 in canine mast cell tumors

Radiology and Oncology
Volume 45 (2011): Issue 1 (March 2011)
By: ,  ,  ,  ,   and    
Open Access
|Sep 2010
References

References

  1. Thamm DH, Vail DM. Mast Cell Tumors. In: Withrow SJ, Wail DM, editors.St. Louis: Saunders; 2007. p. 402-16.
    Open DOISearch in Google Scholar
  2. Maureen C, XinRu T, Benett P. Combination CCNU and Vinblastine chemotherapy for canine mast cell tumors: 57 cases.2009;: 196-206.
    Open DOISearch in Google Scholar
  3. Cemazar M, Tamzali Y, Sersa G, Tozon N. Mir LM, Miklavcic D, et al. Electrochemotherapy in veterinary oncology.2008;: 826-31.
    Open DOISearch in Google Scholar
  4. Mir LM, Glass LF, Sersa G, Teissie J, Domenge C, Miklavcic D, et al. Effective treatment of cutaneous and subcutaneous malignant tumors by electrochemotherapy.1998;: 2336-42.
    Open DOISearch in Google Scholar
  5. Sersa G, Miklavcic D, Cemazar M, Rudolf Z, Pucihar G, Snoj M. Electrochemotherapy in treatment of tumors.2008;: 232-40.
    Open DOISearch in Google Scholar
  6. Gothelf A, Mir LM, Gehl J. Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation.2003;: 371-87.
    Open DOISearch in Google Scholar
  7. Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH. Gene transfer into mouse lyoma cells by electroporation in high electric fields.1982;: 841-5.
    Open DOISearch in Google Scholar
  8. Mir LM. Nucleic acids electrotransfer-based gene therapy (electrogenetherapy): past, current, and future.2009;: 167-76.
    Open DOISearch in Google Scholar
  9. Cemazar M, Golzio M, Sersa G, Rols MP, Teissié J. Electrically-assisted nucleic acids delivery to tissues in vivo: where do we stand?2006;: 3817-25.
    Open DOISearch in Google Scholar
  10. Heller LC, Heller R. In vivo electroporation for gene therapy.2006;: 890-7.
    Open DOISearch in Google Scholar
  11. Fewell JG, MacLaughlin F, Mehta V, Gondo M, Nicol F, Wilson E, et al. Gene therapy for the treatment of hemophilia B using PINC-formulated plasmid delivered to muscle with electroporation.2001;: 574-83.
    Open DOISearch in Google Scholar
  12. Draghia-Akli R, Hahn KA, King GK, Cummings KK, Carpenter RH. Effects of plasmid-mediated growth hormone-releasing hormone in severely debilitated dogs with cancer.2002;: 830-6.
    Open DOISearch in Google Scholar
  13. Pavlin D, Tozon N, Sersa G, Pogacnik A, Cemazar M. Efficient electrotransfection into canine muscle.2008;: 45-54.
    Open DOISearch in Google Scholar
  14. Chou PC, Chuang TF, Jan TR, Gion HC, Huang YC, Lei HJ, et al. Effects of immunotherapy of IL-6 and IL-5 plasmids on transmissible veneral tumor in beagles.2009;: 25-34.
    Open DOISearch in Google Scholar
  15. Chuang, TF, Lee SC, Liao KW, Hsiao YW, Lo CH, Chiang BL, et al. Electroporation-mediated IL-12 gene therapy in a transplantable canine cancer model.2009;: 698-707.
    Open DOISearch in Google Scholar
  16. DelVecchio M, Bajetta E, Canova S, Lotze MT, Wesa A, Parmiani G, et al. Interleukin-12: biological properties and clinical application.2007;: 4677-85.
    Open DOISearch in Google Scholar
  17. Heinzerling LM, Feige K, Rieder S, Akens MK, Dummer R, Stranzinger G, et al. Tumor regression induced by intratumoral injection of DNA coding for human interleukin 12 into melanoma metastases in gray horses.2001;: 692-702.
    Open DOISearch in Google Scholar
  18. Siddiqui F, Li C-Y, LaRue SM, Poulson JM, Avery PR, Pruitt AF, et al. A phase I trial of hyperthermia-induced interleukin-12 gene therapy in spontaneously arising feline soft tissue sarcomas.2007;: 380-9.
    Open DOISearch in Google Scholar
  19. Kamensek U, Sersa G. Targeted gene therapy in radiotherapy.2008;: 115-35.
    Open DOISearch in Google Scholar
  20. Daud AI, DeConti RC, Andrews S, Urbas P, Riker AI, Sondak VK, et al. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.2008;: 5896-903.
    Open DOISearch in Google Scholar
  21. Cemazar M, Jarm T, Sersa G. Cancer Electrogene Therapy with Interleukin-12.2010;: 300-11.
    Open DOISearch in Google Scholar
  22. Patnaik AK, Ehler WY, MacEwen EG. Canine cutaneous mast cell tumors: morphological grading and survival in 83 dogs.1984;: 469-74.
    Open DOISearch in Google Scholar
  23. Buettner M, Belke-Louis G, Rziha HJ, McInnes C, Kaaden OR. Detection, cDNA cloning and sequencing of canine interleukin 12.1998;: 241-8.
    Open DOISearch in Google Scholar
  24. Phillips BS, Padilla ML, Dickerson EB, Lindstrom MJ, Helfand SC. Immunostimulatory effects of human recombinant interleukin-12 on peripheral blood mononuclear cells from normal dogs.1999;: 189-201.
    Open DOISearch in Google Scholar
  25. Tamzali Y, Couderc B, Rols MP, Golzio M, Teissie J. Equine cutaneous tumors treatment by electro-chemo-immuno-therapy. In: Jarm T, Kramar P, Zupanic A, editors., vol 16. New York: Springer; 2007. p. 610-3.
    Search in Google Scholar
  26. Rakhmilevich AL, Timmins JG, Janssen K, Pohlmann EL, Sheehy MJ, Yang NS. Gene gun-mediated IL-12 gene therapy induces antitumor effects in the absence of toxicity: a direct comparison with systemic IL-12 protein therapy.1999;: 135-44.
    Open DOISearch in Google Scholar
  27. Li S, Zhang L, Torrero M, Cannon M, Barret R. Administration route- and immune cell activation-dependant tumor eradication by IL-12 electrotransfer.2005;: 942-9.
    Open DOISearch in Google Scholar
  28. Lucas ML, Heller L, Coppola D, Heller R. IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma.2002;: 668-75.
    Open DOISearch in Google Scholar
  29. Pavlin D, Cemazar M, Kamensek U, Tozon N, Pogacnik A, Sersa G. Local and systemic antitumor effect of intratumoral and peritumoral IL-12 electrogene therapy on murine sarcoma.2009;: 2114-22.
    Open DOISearch in Google Scholar
  30. Tevz G, Kranjc S, Cemazar M, Kamensek U, Coer A, Krizan M, et al. Controlled systemic release of interleukin-12 after gene electrotransfer to muscle for cancer gene therapy alone or in combination with ionizing radiation in murine sarcomas.2009;: 1125-37.
    Open DOISearch in Google Scholar
  31. Lucas ML, Heller R. IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma.2003;: 755-63.
    Open DOISearch in Google Scholar
  32. Lee SC, Wu CJ, Wu PY, Huang YL, Wu CW, Tao MH. Inhibition of established subcutaneous and metastatic murine tumors by intramuscular electroporation of the interleukin-12 gene.2003;: 73-86.
    Open DOISearch in Google Scholar
  33. Leonard JP, Sherman ML, Fisher GL, Buchanan LJ, Larsen G, Atkins MB, et al. Effects of single dose interleukin 12 exposure on interleukin-12 associated toxicity and interferon-gamma production.1997;: 2541-8.
    Search in Google Scholar
  34. Heller L, Merkler K, Westover J, Cruz Y, Coppola D, Benson K, et al. Evaluation of toxicity following electrically mediated interleukin-12 gene delivery in a B16 mouse melanoma model.2006;: 3177-83.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10019-010-0041-9 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 31 - 39
Published on: Sep 22, 2010
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
electroporation,
electrotransfection,
electrogene therapy,
mast cell tumors,
IL-12,
IFN-γ
Related subjects:
Medicine,
Clinical medicine,
Radiology

© 2010 Darja Pavlin, Maja Cemazar, Andrej Cör, Gregor Sersa, Azra Pogacnik, Natasa Tozon, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 45 (2011): Issue 1 (March 2011)
Previous article
Next article